Vivint CEO Deflects Questions About Unethical Sales Practices, "Every Company Has a Few Bad Apples"
Vivint's new CEO emphasized 'a few bad apples' and that 'no company' is 'perfect' responding to questions about US government actions against his company's unethical and illegal actions.
In this report, IPVM examines the Vivint CEO's comments, provides background on the company’s legal troubles and its new court-mandated compliance officer.
For previous coverage: Vivint Illegally Opened "Hundreds of Thousands" of Accounts, Says FTC, Vivint Founder / CEO To Resign, Vivint's Chief Legal Officer Agrees To Step Down, Vivint Replaces Founder With Former COO, Amid Numerous Illegal Activity Complaints.
Vivint ***: ****** ** * "**** *******" **** "*** ******"
******'* *** ***,***** *******, ********* ** *******'* ******** ********'* ****** ** **** ** ********* *** *** ******* ***** ** address *** "******* ********* **** ****** has *** ** *** **** ** terms ** ******* *** **** ********":
**'** *** ****** **** ******.Unfortunately, ***** ******* *** * *** *** ****** and you have to be diligent in making sure that, that apple is not with the company. And you have to be diligent in making sure that we're always retesting, retesting, retesting. And so I **** *** ******* ** **** ******* *** **'* * **** ******* and people are great. So I think we've done a really good job of addressing those issues. We will continue to be very diligent about doing that. [emphasis added]
**** ******* **** *** *** *** the *** ****** ****** ******* ****** for ******* ********** **** ****. *****, Vivint**** *** *** $*.* ******* ** January ******* ******* ***** ********** ** ********* insured ********* ************** * **** ********* ****** ***** reps.****, ****** ******** $** ******* ** *** *** in ***** ******* ********* ******* "******** ** *********" of ******** *** *********** *********.
******'* *** *** *** ******'* *** from **** ** **** ****** *** core ****** ***** *** *** ***** ongoing ******* **********.
CEO ******* ****** ** "***** *** **********"
** *** ****, ******* **** ******* anyone **** ********* ** **** ** him **********, ****** ** *** *** leadership **** **** **** ***** *********:
* **** **** ******* **** ********, but * **** **** **** *******, Brian. ** **anyone **** *** *** ********* ***** ****, **** ** ** **********, this is a very important matter. And I know that resonates with my entire leadership team and our entire committee. [emphasis added]
Declines ** ****
****** ******** ** ***** ** **** after ** ********* ** *** ***'* invitation *** ****** ** ***** ** him ********** ** ***** *******.
"Few *** ******" **. ******** ** ****
****** ********** "******** ** ***** *************** for ********** ******* ** ***** ****** and ************* **-*******" ** ***** ****, per *** ***. **** ** ******* 10% ** ******'* **********, **** ****** ******* **** **** ****** had ~*,*** ************* ****.
***** "******** ** ***** ***************" ** quite *** ******** ** ******'* *** claim ***** **** * "*** *** apples" ********** ***** ** *** *** during *** **** ******.
********, ******'* $** ******* *** **** is******-******* **** *** *** **** ****** Reporting *** ****.
Vague ********** *******
****** *** **** ******* ** ***** "gaps" ** *** ***** *********, *** Bywater ****. *******, ** *** *** further ********* ** **** ************ *** company ** ***** ** *******, *** example, ****** "*** ******", ********** ******* training, ******* ** * ****** ** report ********* ***** ********* *** *********, etc:
*** ******* ******** ********* * *** of ***** ****** *** ****'** **** working ** *** *** **** ******* quarters. ** ****'** ***** ********* ** trying ** ***** **** ** ***** gaps **** **** *** *** **** done * **** ***. ****'** ****** closely **** ********** ******** ** ***** that **** ***** ***** ****.
******, ******* ***** *** ****** ** "trust" *** **** ******* ********** *** auditing ** *******:
*** ** **** ** ******* ********** that **'** ******** ******* ** ** that. ** ***** ** * -- there's * **** ******* ******* ***** me, ***** ** **** *** **** report ***, *** ** **** *********** others ******* **** ** *** **** we **** ** *** ******** ***** team. *** ****'** ****, **** ********* to ****** **** ** ******* *** identify **** *** **** ***** **** closed ** **** ** ******** ** test *** ** *** ********* ****** forward.
Requested *********** ** ********** *******
****** ***** ********* ** ****'* ******** request **** **** * ***** *** on *** ******** ******* **** ***** and ******** ********** *******, *** ****************** ** *** *** ** *** 2021** * **** ** ******'* **********.
New ********** ******* *****
*** *** ******* ****** ** **** a ***** ********** ******* (***), ***** CEO ******* ********** ** *** **** that **** *** ***** *** *** will ** ******* ****, ****** ** further ****** ************ *** *** **** made.
*******, *** *******'* ****** ******** ** replace ****** *** **** ******** **** Bywater, * ****** *** ****** ***** veteran, ***** *** ******* ** *** looking *** ******* **********.******* ******'* *** *** ****** ****** to *** *******’* ******** ******* ** be ****.
Vivint "******** ******" ** **********
******* ***** *** ****** ** ******'* commitment ** ********** ** ********** *** excitement *** *** *** **** *** anticipation **** ****** **** ** *** industry ****** ** **********:
** **** ******* *** **** ****** to ******** ** ******* *** ** the ******** ****** ** ****.
*****... ** *** *******
*** *** **** **** ************ **** with **** *-* ********? *****’* ******* see *** ************* ****? ** *** recent ***** *********** ***** *** ********** of **** ********, **** ***/******, ***********, Vivint, ******** ************* **** **** **** fast ****** $*******(*) ******? **** *** self-destructing *** *** ************ ***** ********** role *** “******** ******”. ….*** ** be ********, *** ********** ******* ** opportunity.
******: *** *****; ******* ******** *****
*** *** **** **** ************ **** with **** *-* ********? *****’* ******* see *** ************* ****?
*** *** ***-******* ***** *** **** picked…
*****... **** ***********.... *** *** ******* fruit ** *** **** *** *******.
***** ****** *****.... *** ****. **** patient ***** ***** *******, *** ******** therapy.
***** **** ******* ** *** *** apple ****.